Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Smallcaps completely out of favour
Thu, 9 Dec 01:30 pm

Continued selling pressure led the Indian markets to decline during the previous two hours of trade. Stocks from the consumer durables, realty and auto spaces are leading the pack of losers. IT and FMCG stocks are amongst the top performers.

The BSE-Sensex is currently trading down by around 170 points (down 0.9%), while the NSE-Nifty is down by about 55 points (down 1%). Stocks from the mid and small cap spaces are under pressure as the BSE-Midcap and BSE-Smallcap indices are trading lower by 2.8% and 4% respectively.

Metal stocks are trading weak led by Hindustan Zinc, Hindalco and Ispat Inds. However, selected stock such as Jindal Saw and Mah. Seamless are trading marginally in the green. Novelis, the Canadian unit of Hindalco, on Friday will close a deal that will refinance the debt taken by Hindalco, but at a higher rate. The Aditya Birla group has mandated five banks for the US$ 4 bn loan-cum-bond financing that will partly refinance the loans that were taken when Hindalco acquired Novelis for US$ 6 bn in 2007. The rate of interest for the loan-cum-bond issue would be about 7%. The deal will be split into a US$ 2.5 bn seven year bond and a US$ 1.5 bn senior secured term loan. There is also an US$ 800 m asset-backed revolving credit facility.

At about 7%, the pricing of the bond issue will be costlier than the five-year loan of US$ 1 bn that Hindalco had raised in 2008, at 315 basis points above the Libor. The move to raise funds will deleverage Hindalco so that it can focus on expansion projects.

A leading business daily has reported that Rallis India has acquired majority stake in a Bangalore based seeds research company named Metahelix Life Sciences. The consideration for the same is Rs 995 m, which has been funded through an all cash transaction. As per the company, this is its first inorganic foray into seeds, which is a key focus area for the firm. Rallis has acquired about 53.5% stake in Metahelix and further plans to infuse abut Rs 250 m to raise its stake to a little over 59%. It also added that it plans to acquire full stake over a period of five years. As per Rallis’ director, expectations are of Metahelix to exceed revenues of Rs 10 bn cumulatively over a period of five years. During FY10, the company reported revenues of a little over Rs 9 bn, while revenues during 1HFY11 stood at Rs 5.7 bn.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Smallcaps completely out of favour". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.